ARTICLE | Management Tracks
FDA vet Singh joining CRDO Precision for Medicine
Plus: de Moerlooze to depart Bavarian and updates from Engitix, Actio and Oruka
May 22, 2024 11:32 PM UTC
Precision for Medicine Inc. said FDA veteran Harpreet Singh has become CMO of the biomarker-driven clinical research and development services company. At FDA, Singh was director of the Division of Oncology 2 and co-leader of Project Pragmatica, which seeks to improve efficiencies in clinical trial procedures and enhance patient centricity using real-world routine clinical practice.
Laurence de Moerlooze will depart Bavarian Nordic A/S (CSE:BAVA; Pink:BVNRY) as EVP and CMO to pursue new opportunities. The Danish company will begin a search for a successor. ...